RARX
Swiss National Bank’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-59,400
| Closed | -$2.85M | – | 2587 |
|
|
2020
Q1 | $2.85M | Buy |
59,400
+900
| +2% | +$43.2K | ﹤0.01% | 1233 |
|
|
2019
Q4 | $2.75M | Buy |
58,500
+7,000
| +14% | +$328K | ﹤0.01% | 1542 |
|
|
2019
Q3 | $1.22M | Buy |
51,500
+2,200
| +4% | +$52K | ﹤0.01% | 1956 |
|
|
2019
Q2 | $1.48M | Buy |
49,300
+1,700
| +4% | +$51.1K | ﹤0.01% | 1887 |
|
|
2019
Q1 | $1.07M | Hold |
47,600
| – | – | ﹤0.01% | 2027 |
|
|
2018
Q4 | $866K | Buy |
+47,600
| New | +$866K | ﹤0.01% | 2084 |
|
|
2018
Q2 | – | Sell |
-33,400
| Closed | -$177K | – | 2546 |
|
|
2018
Q1 | $177K | Buy |
33,400
+20,200
| +153% | +$107K | ﹤0.01% | 2477 |
|
|
2017
Q4 | $112K | Hold |
13,200
| – | – | ﹤0.01% | 2512 |
|
|
2017
Q3 | $193K | Hold |
13,200
| – | – | ﹤0.01% | 2517 |
|
|
2017
Q2 | $247K | Buy |
+13,200
| New | +$247K | ﹤0.01% | 2542 |
|